THU0635 Defining The Optimal Biological Monotherapy in Rheumatoid Arthritis: A Systematic Review and Network Meta-Analysis of Randomised Trials

S Tarp; D E Furst; A Døssing; M Østergaard; T Lorenzen; M Hansen; J Singh; E Choy; M. Boers; M Suarez-Almazor; L Kristensen; H Bliddal; R Christensen

doi:10.1136/annrheumdis-2016-eular.1375

THU0635 Defining The Optimal Biological Monotherapy in Rheumatoid Arthritis: A Systematic Review and Network Meta-Analysis of Randomised Trials

S Tarp, D E Furst, A Døssing, M Østergaard, T Lorenzen, M Hansen, J Singh, E Choy, M. Boers, M Suarez-Almazor, L Kristensen, H Bliddal, R Christensen

Department of Clinical Medicine

Original language	English
Journal	Annals of the Rheumatic Diseases
Volume	75
Issue number	Suppl 2
Pages (from-to)	423-424
Number of pages	2
ISSN	0003-4967
DOIs	https://doi.org/10.1136/annrheumdis-2016-eular.1375
Publication status	Published - 2016

Access to Document

10.1136/annrheumdis-2016-eular.1375

Cite this

Tarp, S., Furst, D. E., Døssing, A., Østergaard, M., Lorenzen, T., Hansen, M., Singh, J., Choy, E., Boers, M., Suarez-Almazor, M., Kristensen, L., Bliddal, H., & Christensen, R. (2016). THU0635 Defining The Optimal Biological Monotherapy in Rheumatoid Arthritis: A Systematic Review and Network Meta-Analysis of Randomised Trials. Annals of the Rheumatic Diseases, 75(Suppl 2), 423-424. https://doi.org/10.1136/annrheumdis-2016-eular.1375

THU0635 Defining The Optimal Biological Monotherapy in Rheumatoid Arthritis : A Systematic Review and Network Meta-Analysis of Randomised Trials. / Tarp, S; Furst, D E; Døssing, A et al.

In: Annals of the Rheumatic Diseases, Vol. 75, No. Suppl 2, 2016, p. 423-424.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Tarp, S, Furst, DE, Døssing, A, Østergaard, M, Lorenzen, T, Hansen, M, Singh, J, Choy, E, Boers, M, Suarez-Almazor, M, Kristensen, L, Bliddal, H & Christensen, R 2016, 'THU0635 Defining The Optimal Biological Monotherapy in Rheumatoid Arthritis: A Systematic Review and Network Meta-Analysis of Randomised Trials', Annals of the Rheumatic Diseases, vol. 75, no. Suppl 2, pp. 423-424. https://doi.org/10.1136/annrheumdis-2016-eular.1375

@article{d0bd630d78c3457bb007f3eda364622c,

title = "THU0635 Defining The Optimal Biological Monotherapy in Rheumatoid Arthritis: A Systematic Review and Network Meta-Analysis of Randomised Trials",

author = "S Tarp and Furst, {D E} and A D{\o}ssing and M {\O}stergaard and T Lorenzen and M Hansen and J Singh and E Choy and M. Boers and M Suarez-Almazor and L Kristensen and H Bliddal and R Christensen",

year = "2016",

doi = "10.1136/annrheumdis-2016-eular.1375",

language = "English",

volume = "75",

pages = "423--424",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "B M J Group",

number = "Suppl 2",

}

TY - ABST

T1 - THU0635 Defining The Optimal Biological Monotherapy in Rheumatoid Arthritis

T2 - A Systematic Review and Network Meta-Analysis of Randomised Trials

AU - Tarp, S

AU - Furst, D E

AU - Døssing, A

AU - Østergaard, M

AU - Lorenzen, T

AU - Hansen, M

AU - Singh, J

AU - Choy, E

AU - Boers, M.

AU - Suarez-Almazor, M

AU - Kristensen, L

AU - Bliddal, H

AU - Christensen, R

PY - 2016

Y1 - 2016

U2 - 10.1136/annrheumdis-2016-eular.1375

DO - 10.1136/annrheumdis-2016-eular.1375

M3 - Conference abstract in journal

SN - 0003-4967

VL - 75

SP - 423

EP - 424

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

IS - Suppl 2

ER -